Pharma bets a little-known form of cholesterol will underpin its next blockbuster heart drugs [MSNBC.com]
Amgen Inc. (AMGN)
Last amgen inc. earnings: 4/30 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.amgen.com
Company Research
Source: MSNBC.com
How much Lp(a) a person has circulating in their body is almost entirely determined by their genes. style factors like diet and exercise don't influence Lp(a) levels like they do LDL levels, leaving people with few good options to reduce it.Currently, doctors encourage people to focus on the factors they can change, such as lowering their LDL cholesterol, decreasing blood pressure, treating obesity and diabetes and exercising. Those strategies can help protect people from high Lp(a) for some time, Nissen said. New medicines could treat people for a longer time.Novartis, Amgen and Lilly have already proven their experimental drugs slash levels of Lp(a) by more than 80%. Now, they will need to show that translates into tangible benefits. If that happens, the drugs could reach annual sales of $5.6 billion by 2032, according to consensus estimates from Evaluate, a pharmaceutical commercial intelligence firm."We don't know how much you have to lower levels," Nissen said. "We don't know how
Show less
Read more
Impact Snapshot
Event Time:
AMGN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AMGN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AMGN alerts
High impacting Amgen Inc. news events
Weekly update
A roundup of the hottest topics
AMGN
News
- FDA Announces Major Steps to Implement Real-Time Clinical Trials [Yahoo! Finance]Yahoo! Finance
- Paradigm Health Announces Collaboration with the FDA to Transform Regulatory Review of Clinical Trial Data [Yahoo! Finance]Yahoo! Finance
- Amgen (AMGN) had its price target raised by Morgan Stanley from $309.00 to $326.00. They now have an "equal weight" rating on the stock.MarketBeat
- Why Amgen Inc. (AMGN) is One of the Best Stem Cell Therapy Stocks to Buy [Yahoo! Finance]Yahoo! Finance
- AMGEN ANNOUNCES WEBCAST OF 2026 FIRST QUARTER FINANCIAL RESULTS [TheStreet.com]TheStreet.com
AMGN
Earnings
- 2/3/26 - Beat
AMGN
Sec Filings
- 4/29/26 - Form SCHEDULE
- 4/22/26 - Form 8-K
- 4/21/26 - Form DEFA14A
- AMGN's page on the SEC website